Is an antioxidative capacity of HI-6 oxime a key factor to improve the therapy with irinotecan?

• 作者Suzana Berend; Ana Lucic Vrdoljak; Bozica Radic; Jasenka Piljac-Zegarac; Marin Mladinic; Davor Zeljezic; Nevenka Kopjar
• 卷第180卷
• 文件大小84.99KB
• 发表时间2008
• DOI10.1016/j.toxlet.2008.06.329